Somebody has said the words to you, or you have found them yourself at two in the morning, and what you have read since has been split between people saying it is a life sentence and people saying it is not real. Both of those are wrong, and the research that shows they are wrong has been sitting in journals for twenty years.

The short answer: borderline personality disorder describes a pattern of intense and rapidly shifting emotion, unstable relationships, an unstable sense of self, and impulsive or self-destructive behaviour, and it is one of the few conditions in psychiatry where structured psychotherapy is the treatment and medication is not. The part that goes untold: in a study that followed 290 severely ill inpatients for sixteen years, 99 percent had a two-year period without meeting criteria and 78 percent had an eight-year one. Symptoms remit far more reliably than life gets rebuilt — recovery, defined as remission plus work and a close relationship, reached 60 percent at two years and 40 percent at eight — and that gap is the honest shape of the problem. Not "will this ever stop." It stops. The question is what is left standing when it does, and that is what treatment is for.¹ ² ³

Four doors

  • This is about me. Start with what the follow-up studies found — does BPD get better? → — then the treatment section below.
  • This is about someone I love. The burden on families is measurable and larger than for most other serious mental illnesses, and there is a free programme for relatives. Loving someone with BPD →
  • This is about my teenager. The diagnosis can be made under 18, guidelines say so explicitly, and the argument about whether it should be is worth understanding before you walk into the appointment. Can a teenager be diagnosed with BPD? →
  • I am not sure this is the right diagnosis. The most common confusion is with bipolar disorder, in both directions, and the feature everyone focuses on is the one that discriminates worst. BPD or bipolar? →

What the diagnosis actually describes

Nine features. A diagnosis requires five, which means two people with the same label can share as little as one. That is worth knowing before you read anything else about "people with BPD."

The criterion What it looks like from inside
Frantic efforts to avoid abandonment Reading a delayed text as the end of something, and the panic arriving before the thought does
Unstable, intense relationships The same person is the only one who understands you and the one who has betrayed you, sometimes in a week
Identity disturbance Not knowing what you want, believe, or are, when the room changes
Impulsivity in at least two damaging areas Spending, sex, substances, driving, eating — the thing that makes the feeling stop for an hour
Recurrent suicidal behaviour, gestures, threats, or self-harm The most visible criterion, and the one that gets people treated badly in emergency rooms
Affective instability Hours, not weeks; and reactive to what just happened
Chronic emptiness The one people rarely mention out loud
Inappropriate, intense anger Or the reverse — anger that is never expressed and turns inward
Transient paranoid ideation or dissociation under stress Going somewhere else while your body stays in the room

Two of these turn out to matter more than the rest for telling BPD apart from other conditions. In a study comparing 53 people with BPD and 83 with bipolar disorder, fear of abandonment had a positive predictive value of 0.90, and abandonment fears and identity disturbance each classified correctly 85 percent of the time — while affective instability, the feature the label is famous for, had the lowest specificity of the nine.⁴ The mood swings are not the signal. The relationship to other people and to yourself is.

What the long studies found

This is the section to read twice.

The McLean Study of Adult Development followed 290 people hospitalised with BPD, aged 18 to 35 at intake, for more than two decades. At the sixteen-year mark:³

Outcome People with BPD Comparison group with other personality disorders
A remission lasting 2 years 99% 99%
A remission lasting 8 years 78% 97%
A recovery lasting 2 years — remission plus a close relationship and consistent work or school 60% 85%
A recovery lasting 8 years 40% 75%
Recurrence after a 2-year remission 36% 7%
Recurrence after an 8-year remission 10% 4%

The authors' own summary: "sustained symptomatic remission is substantially more common than sustained recovery from borderline personality disorder."³

The Collaborative Longitudinal Personality Disorders Study followed 175 treatment-seeking outpatients for ten years and found the same shape from a different angle: 85 percent remitted using a twelve-month definition, only 11 percent relapsed, the average number of criteria met fell from 6.7 to 1.7 — and global functioning scores moved from 53 to 57. Full-time employment rose from 19 percent to 36 percent. The authors' conclusion: "high rates of remission, low rates of relapse, and severe and persistent impairment in social functioning."²

So: the symptoms go. The life does not rebuild itself while they are going. That is not a counsel of despair — it is the argument for treatment that works on functioning and not only on symptoms, and for starting it before a decade has passed.

One caution about generalising. Both studies followed people who were severely ill and in treatment; the McLean cohort were inpatients. Most people who meet criteria for BPD are not in a study, and their course is less well described.

Two things you will read that are wrong

"About ten percent of people with BPD die by suicide." That figure comes from follow-back studies of patients discharged from long-stay specialist units decades ago.⁵ In the McLean cohort followed prospectively for 24 years, 5.9 percent died by suicide; a meta-analysis of prospective clinical cohorts puts the range at 2 to 5 percent.⁶ ⁷ The risk is real and it is not the number people repeat. Worth knowing alongside it: in the same 24 years, 14 percent died of causes that were not suicide — the larger absolute figure, and the one nobody quotes.⁶ Physical health is part of this.

"Three out of four people with BPD are women." True of clinics. In the largest general-population survey, 5.6 percent of men and 6.2 percent of women met lifetime criteria; a reanalysis applying a distress and impairment requirement found 2.4 percent of men and 3.0 percent of women.⁸ ⁹ Clinical caseloads run about three-quarters female. The most likely explanation is not that men do not have it but that they arrive somewhere else — addiction services, the criminal system — and get a different label.¹⁰

And on prevalence generally: the headline 5.9 percent from that survey is the highest figure in the literature and is repeated without its caveats. The defensible range is roughly 1 to 3 percent of the general population; the UK's national guideline says just under 1 percent. In clinical settings the figures are far higher — around 10 to 12 percent of psychiatric outpatients and 20 to 22 percent of inpatients.⁸ ⁹ ¹¹

What treats it

Psychotherapy. Not as a preference — as the finding.

The Cochrane review of psychological therapies pooled 75 randomised trials and 4,507 participants. Compared with usual treatment, BPD-tailored psychotherapy improved BPD symptom severity with a standardised mean difference of −0.52, rated moderate-quality evidence, and it was the only outcome that cleared the review's own threshold for a clinically meaningful difference. Self-harm, suicide-related outcomes and psychosocial functioning all improved but did not reach that threshold, on low-quality evidence.¹²

The finding people do not expect: no named therapy beat any other. The review's own words — "Subgroup analyses found no evidence of a difference in effect estimates between the different types of therapies."¹² A later network meta-analysis of 43 studies reached the same place: "no single treatment seems to be the best choice."¹³

Treatment What it is The key trial
Dialectical behaviour therapy (DBT) Individual therapy, a skills group, phone coaching, and a therapist consultation team, usually about a year Halved the rate of suicide attempts against treatment by community experts, over two years, in 101 women¹⁴ · What a full DBT programme includes →
Good psychiatric management (GPM) Structured, sensible psychiatric care by a clinician who understands BPD — not a specialist brand Matched DBT on every outcome in 180 patients over a year¹⁵
Mentalization-based treatment (MBT) Building the capacity to read your own and others' mental states, individually and in groups Outperformed structured clinical management on crisis events in 134 outpatients¹⁶
Transference-focused psychotherapy (TFP) A structured psychodynamic treatment focused on the therapy relationship Improved multiple domains across 90 patients in a three-arm trial¹⁷
Schema therapy Working on long-standing self-defeating patterns and the modes they run in Three years of twice-weekly therapy in 88 patients¹⁸
STEPPS A 20-week skills group added on top of existing care Improved BPD symptoms in 124 patients — but not suicide attempts, self-harm or hospitalisation¹⁹

The McMain trial deserves its own paragraph, because it is the most useful finding in this whole literature for anyone who cannot find a DBT programme. One hundred and eighty people with recent suicidal or self-injurious behaviour were randomised to a year of DBT or a year of general psychiatric management. Both groups improved substantially on nearly everything, and "no significant differences across any outcomes were found between groups."¹⁵ A well-organised, informed, consistent psychiatrist or therapist is not a consolation prize.

And the honest counterweight. At three years in the same trial, two-thirds of participants had achieved diagnostic remission — and 53 percent were neither employed nor in school, and 39 percent were receiving psychiatric disability support.²⁰ Symptom remission and a rebuilt life are different targets. Ask your treatment which one it is aiming at.

About dropout. Roughly 22 percent across all trials and 28 percent in outpatient randomised trials, and most of it happens in the first half of treatment.²¹ If you have left treatment before, you are the majority case, not a failure case; and the first months are the ones to plan for.

What does not treat it

No medication holds a licensed indication for BPD in the United States: every prescription for the disorder itself is off-label.²² The Cochrane review of drug treatment covered 46 randomised trials and 2,769 participants and found that "compared with placebo, no difference in effects were observed on any of the primary outcomes at the end of treatment for any medication," concluding that "no pharmacological therapy seems effective in specifically treating BPD pathology."²³ The UK guideline is blunter still: drug treatment "should not be used specifically for borderline personality disorder or for the individual symptoms or behaviour associated with the disorder."²⁴

That is not an argument for stopping anything you are taking, and it is not an argument against treating a depression, an anxiety disorder, ADHD or a substance use disorder that is genuinely there. It is an argument against accumulating drugs for the diagnosis itself — which is what happens: in a whole-country prescribing study, 55.9 percent of people with BPD who were dispensed any medication were on three or more psychotropics, and 10.7 percent on seven or more.²⁵ The full medication answer →

Getting treated in California

  • Start with the diagnosis being made properly. BPD is under-detected in ordinary intake interviews and over-attributed after a crisis; the UK quality standard asks for a structured clinical assessment, and it is reasonable to ask whether one was used.²⁶ If a diagnosis was made in an emergency room, that is precisely the circumstance the guidelines say should be revisited.²⁴
  • Ask your health plan for the level of care, not the brand. California's parity law requires plans to cover medically necessary mental health treatment on the same terms as medical treatment, including intermediate levels of care. If a plan denies a programme, that is an appealable decision with a free regulator behind it. Appeal a denial → · If nobody in-network has an appointment →
  • Check the programme before you commit a year to it. "DBT-informed" is not DBT, and the difference is four specific components. The printable programme check →
  • If money is the obstacle, county behavioural health and sliding-scale routes both exist, and neither requires you to have exhausted the other. What a sliding scale actually is → · What changed at your county →
  • If a crisis is the immediate problem, 988 is free and 24/7, and there are routes into help that do not run through the police. Crisis without police →

For the people around you

Relatives of people with BPD report burden and grief measurably higher than relatives of people with other serious mental illnesses — about half a standard deviation higher on burden in a review of 465 carers.²⁷ There is a free twelve-week programme built for them, delivered online, and a national family education course besides. Both are covered, with an honest read of how strong their evidence actually is, on the family page.

Q&A

Q: Is borderline personality disorder permanent? A: No. In a sixteen-year prospective follow-up of 290 hospitalised patients, 99 percent achieved a two-year remission and 78 percent an eight-year one.³ In a ten-year follow-up of 175 outpatients, 85 percent remitted and 11 percent relapsed.² What persists in both studies is impairment in work and relationships, which is why treatment aimed only at symptoms is aiming at half the problem.

Q: Is it a personality flaw, or an illness? A: It is a diagnosis describing a pattern of emotion, relationships and self-image that causes suffering and impairment, and it responds to specific treatments. The word "personality" in the name has done a great deal of damage, because it reads as a verdict on who somebody is rather than a description of what is happening to them.

Q: Can it be diagnosed alongside something else? A: Usually it is. Depression, PTSD, anxiety disorders, substance use disorders and eating disorders are all common alongside it, and guidelines say to treat the comorbid condition on its own evidence while the BPD treatment continues.²⁴

Q: What if I have BPD and bipolar disorder? A: Around one in five people with one meets criteria for the other, so it happens — but in 80 to 90 percent of cases each is diagnosed without the other.²⁸ If both are present, both get treated, on their own guidelines. The full differential →

Q: Do I have to have a diagnosis to get DBT? A: The treatments were built for BPD but skills groups are widely offered to people with emotion regulation difficulties who have never been diagnosed. What a diagnosis changes is what your insurer will authorise and what a clinician thinks they are treating.

Q: Should I tell people? A: That is yours to decide case by case, and stigma about this diagnosis is real and documented, including among clinicians. Telling a treating clinician is different from telling an employer. Workplace accommodations →

Ready to find a therapist who actually runs a structured treatment? Filter by approach, schedule and payment route → · What to ask on the consult call →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Bohus M, Stoffers-Winterling J, Sharp C, Krause-Utz A, Schmahl C, Lieb K, "Borderline personality disorder," The Lancet 398(10310), 2021, 1528–1540 — "Psychotherapy is the main treatment for BPD; drug treatment is only indicated for comorbid conditions that require medication, or during a crisis if psychosocial interventions are insufficient" — doi.org.
  2. Gunderson JG, Stout RL, McGlashan TH, et al., "Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study," Archives of General Psychiatry 68(8), 2011, 827–837 — 85% cumulative remission on the 12-month definition, 11% relapse, GAF 53 to 57, full-time employment 19% to 36%; "high rates of remission, low rates of relapse, and severe and persistent impairment in social functioning" — pmc.ncbi.nlm.nih.gov.
  3. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G, "Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study," American Journal of Psychiatry 169(5), 2012, 476–483 — remission 78–99%, recovery 40–60%; "sustained symptomatic remission is substantially more common than sustained recovery" — pmc.ncbi.nlm.nih.gov.
  4. Bayes AJ, Parker GB, "Differentiating borderline personality disorder (BPD) from bipolar disorder: diagnostic efficiency of DSM BPD criteria," Acta Psychiatrica Scandinavica 141(2), 2020, 142–148 — abandonment fears PPV 0.90; abandonment fears and identity disturbance 85% classification accuracy; affective instability lowest specificity — europepmc.org.
  5. Paris J, Zweig-Frank H, "A 27-year follow-up of patients with borderline personality disorder," Comprehensive Psychiatry 42(6), 2001, 482–487 — "The total percentage of suicides from the original cohort has reached 10.3%" — pubmed.ncbi.nlm.nih.gov; Paris J, "Suicidality in borderline personality disorder," Medicina 55(6), 2019, 223 — "lower rates (3%–6%) have been reported in prospectively followed cohorts" — mdpi.com.
  6. Temes CM, Frankenburg FR, Fitzmaurice GM, Zanarini MC, "Deaths by suicide and other causes among patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up," Journal of Clinical Psychiatry 80(1), 2019, 18m12436 — "A total of 5.9% of borderline patients and 1.4% of comparison subjects died by suicide… 14.0% of borderline patients and 5.5% of comparison subjects died by non-suicide causes" — pubmed.ncbi.nlm.nih.gov.
  7. Álvarez-Tomás I, Ruiz J, Guilera G, Bados A, "Long-term clinical and functional course of borderline personality disorder: a meta-analysis of prospective studies," European Psychiatry 56, 2019, 75–83 — "Mean suicide rate ranged from 2% to 5%" — pubmed.ncbi.nlm.nih.gov.
  8. Grant BF, Chou SP, Goldstein RB, et al., "Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder," Journal of Clinical Psychiatry 69(4), 2008, 533–545 — lifetime prevalence 5.9%; "There were no differences in the rates of BPD among men (5.6%…) and women (6.2%…)" — pmc.ncbi.nlm.nih.gov.
  9. Tomko RL, Trull TJ, Wood PK, Sher KJ, "Characteristics of borderline personality disorder in a community sample," Journal of Personality Disorders 28(5), 2014, 734–750 — 2.7% applying distress and impairment; 3.0% of females and 2.4% of males — pmc.ncbi.nlm.nih.gov.
  10. Skodol AE, Bender DS, "Why are women diagnosed borderline more than men?" Psychiatric Quarterly 74(4), 2003, 349–360 — "The differential gender prevalence of BPD in clinical settings appears to be largely a function of sampling bias" — pubmed.ncbi.nlm.nih.gov.
  11. Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M, "Community and clinical epidemiology of borderline personality disorder," Psychiatric Clinics of North America 41(4), 2018, 561–573 — "the prevalence is around 10% to 12% in outpatient psychiatric clinics and 20% to 22% among inpatient clinics" — pubmed.ncbi.nlm.nih.gov; National Institute for Health and Care Excellence, clinical guideline CG78 — "present in just under 1% of the population" — nice.org.uk.
  12. Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al., "Psychological therapies for people with borderline personality disorder," Cochrane Database of Systematic Reviews 5, 2020, CD012955 — 75 trials, 4,507 participants; BPD severity SMD −0.52 (95% CI −0.70 to −0.33), moderate-quality evidence and the only outcome to reach the review's minimal clinically relevant difference; "Subgroup analyses found no evidence of a difference in effect estimates between the different types of therapies" — doi.org.
  13. Setkowski K, Palantza C, van Ballegooijen W, et al., "Which psychotherapy is most effective and acceptable in the treatment of adults with a (sub)clinical borderline personality disorder? A systematic review and network meta-analysis," Psychological Medicine 53(8), 2023, 3261–3280 — "no single treatment seems to be the best choice to treat people with BPD compared to other treatments" — europepmc.org.
  14. Linehan MM, Comtois KA, Murray AM, et al., "Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder," Archives of General Psychiatry 63(7), 2006, 757–766 — 101 women; "Subjects receiving DBT were half as likely to make a suicide attempt (hazard ratio, 2.66; P = .005)" — doi.org.
  15. McMain SF, Links PS, Gnam WH, et al., "A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder," American Journal of Psychiatry 166(12), 2009, 1365–1374 — 180 patients; "No significant differences across any outcomes were found between groups" — doi.org.
  16. Bateman A, Fonagy P, "Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder," American Journal of Psychiatry 166(12), 2009, 1355–1364 — 134 patients — pubmed.ncbi.nlm.nih.gov.
  17. Clarkin JF, Levy KN, Lenzenweger MF, Kernberg OF, "Evaluating three treatments for borderline personality disorder: a multiwave study," American Journal of Psychiatry 164(6), 2007, 922–928 — 90 patients — pubmed.ncbi.nlm.nih.gov.
  18. Giesen-Bloo J, van Dyck R, Spinhoven P, et al., "Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy," Archives of General Psychiatry 63(6), 2006, 649–658 — 88 patients, three years of twice-weekly therapy — pubmed.ncbi.nlm.nih.gov.
  19. Blum N, St John D, Pfohl B, et al., "Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder," American Journal of Psychiatry 165(4), 2008, 468–478 — 124 subjects analysed; "There were no differences between groups for suicide attempts, self-harm acts, or hospitalizations" — pubmed.ncbi.nlm.nih.gov.
  20. McMain SF, Guimond T, Streiner DL, Cardish RJ, Links PS, "Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: clinical outcomes and functioning over a 2-year follow-up," American Journal of Psychiatry 169(6), 2012, 650–661 — "even though two-thirds of the participants achieved diagnostic remission… 53% were neither employed nor in school, and 39% were receiving psychiatric disability support after 36 months" — pubmed.ncbi.nlm.nih.gov.
  21. Iliakis EA, Ilagan GS, Choi-Kain LW, "Dropout rates from psychotherapy trials for borderline personality disorder: a meta-analysis," Personality Disorders: Theory, Research, and Treatment 12(3), 2021, 193–206 — "Dropout rates were 22.3% considering all studies, and 28.2% when only considering outpatient randomized controlled trials… Most dropouts occurred in the first half of treatment" — pubmed.ncbi.nlm.nih.gov.
  22. US Food and Drug Administration, structured product labelling database (openFDA), searched September 2026 — no US drug label lists borderline personality disorder in its Indications and Usage section — open.fda.gov.
  23. Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, et al., "Pharmacological interventions for people with borderline personality disorder," Cochrane Database of Systematic Reviews 11, 2022, CD012956 — 46 trials, 2,769 participants; "Compared with placebo, no difference in effects were observed on any of the primary outcomes at the end of treatment for any medication"; "no pharmacological therapy seems effective in specifically treating BPD pathology" — pmc.ncbi.nlm.nih.gov.
  24. National Institute for Health and Care Excellence, "Borderline personality disorder: recognition and management," clinical guideline CG78, 2009 — recommendation 1.3.5.1, "Drug treatment should not be used specifically for borderline personality disorder or for the individual symptoms or behaviour associated with the disorder"; recommendation 1.3.6.1, review the diagnosis "especially if either diagnosis has been made during a crisis"; recommendation 1.3.6.2 on treating comorbid conditions within a structured programme — nice.org.uk.
  25. Tennant M, Frampton C, Mulder R, Beaglehole B, "Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databases," BJPsych Open 9(6), 2023, e200 — 55.9% on three or more psychotropics in 2019; 10.7% on seven or more — pmc.ncbi.nlm.nih.gov.
  26. National Institute for Health and Care Excellence, "Personality disorders: borderline and antisocial," quality standard QS88, quality statement 1, 2015 — "Mental health professionals use a structured clinical assessment to diagnose borderline or antisocial personality disorder" — nice.org.uk; Zimmerman M, Mattia JI, "Differences between clinical and research practices in diagnosing borderline personality disorder," American Journal of Psychiatry 156(10), 1999, 1570–1574 — "Without the benefit of detailed information from a semistructured diagnostic interview, clinicians rarely diagnose the disorder during a routine intake evaluation" — europepmc.org.
  27. Bailey RC, Grenyer BFS, "Burden and support needs of carers of persons with borderline personality disorder: a systematic review," Harvard Review of Psychiatry 21(5), 2013, 248–258 — 465 carers; "Scores on objective and subjective burden were half a standard deviation above the mean compared to carers of inpatients with other serious mental illnesses" — doi.org.
  28. Zimmerman M, Morgan TA, "Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder," Current Psychiatry Reports 15(12), 2013, 422 — "each disorder is, nonetheless, diagnosed in the absence of the other in the vast majority of cases (80-90%)" — europepmc.org.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.